Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Statement re. Suspension

3 Apr 2006 16:32

Capricorn Resources PLC03 April 2006 CAPRICORN RESOURCES PLC SUSPENSION OF TRADING The Directors of Capricorn Resources PLC ("Capricorn") note that trading in itsOrdinary Shares and Warrants on the AIM Market of the London Stock Exchange hasbeen suspended today under the rule relating to investing companies. TheDirectors further note that, unless Capricorn completes a reverse transaction inaccordance with the rules, its admission to AIM will be cancelled on 30September 2006. The Directors of Capricorn have reached agreement in principle for theacquisition of a company operating in the on-shore natural gas sector in theUnited Kingdom, and holding a petroleum licence which includes a small gas fieldin Derbyshire. The recent increase in gas prices mean that it can be economic toproduce gas from a small field and the intention is to bring this field intoproduction within six months of completion of the acquisition. The licence alsoincludes abandoned mine workings and it will be Capricorn's intention in thelonger term to explore for and produce coal bed methane, including gasassociated with abandoned mine workings, both on this licence and in other areasof Great Britain, and to develop gas storage facilities within such workings. The proposed acquisition will be conditional, inter alia, on completion of duediligence, including a valuation of the assets to be acquired, on the raising offurther cash intended to be provided by the exercise of part of Capricorn'soutsanding Warrants, and on confirmation of certain regulatory matters. Amongthe requirements is approval by Capricorn shareholders in general meeting as aspecial resolution. As one shareholder grouping controls more than 25% ofCapricorn's shares the approval of that group is essential for any resolution tobe passed and will be sought by the Directors prior to signing a bindingcontract. Should this agreement not be forthcoming the transaction will not be able toproceed, and for that reason the Directors will continue to examine otherpossible deals with a view to completing a transaction before 30 September 2006. Shareholders will be kept informed of developments. Contact: Brian Moritz (Chairman) 07976 994300 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
18th Jan 20192:22 pmRNSBlock listing Interim Review
4th Jan 20191:48 pmRNSResult of General Meeting
4th Jan 20197:00 amRNSGeneral Meeting Business Update
31st Dec 20187:00 amRNSTotal Voting Rights
27th Dec 20187:00 amRNSHolding(s) in Company
17th Dec 20187:00 amRNSListing Rule 9.6.14(R) Disclosure
11th Dec 201812:10 pmRNSOption exercised for Tudorza from AstraZeneca
10th Dec 20185:59 pmRNSPosting of Shareholder Circular
10th Dec 201812:59 pmRNSProposed admission to trading on AIM
30th Nov 20187:00 amRNSTotal Voting Rights
31st Oct 20182:13 pmRNSTotal Voting Rights
25th Oct 20183:00 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSTotal Voting Rights
27th Sep 20187:00 amRNSInterim Results for Six Months Ended 30 June 2018
7th Sep 201811:36 amRNSNotice of Interim Results and Broker Appointment
3rd Sep 201812:15 pmRNSTotal Voting Rights
16th Aug 20184:25 pmRNSDirector Declaration
13th Aug 20187:00 amRNSRegulatory Application
31st Jul 20187:00 amRNSTotal Voting Rights
18th Jul 20184:14 pmRNSHolding(s) in Company
18th Jul 20184:12 pmRNSHolding(s) in Company
18th Jul 20184:11 pmRNSHolding(s) in Company
18th Jul 20181:52 pmRNSIssue of Equity and Total Voting Rights
16th Jul 20183:28 pmRNSResult of AGM
2nd Jul 20187:00 amRNSBlock listing Interim Review
29th Jun 20187:00 amRNSTotal Voting Rights
27th Jun 201812:23 pmRNSPublication of Circular
11th Jun 20184:20 pmRNSHolding(s) in Company
4th Jun 20184:18 pmRNSDirector/PDMR Shareholding
4th Jun 20184:15 pmRNSDirector/PDMR Shareholding
4th Jun 20184:14 pmRNSDirector/PDMR Shareholding
1st Jun 20187:00 amRNSUS Filing of Duaklir NDA & Tudorza Supplement NDA
31st May 20187:00 amRNSTotal Voting Rights
30th May 201812:05 pmRNSResult of AGM
22nd May 20187:00 amRNSPositive Data Presented at 2018 ATS Conference
18th May 201810:57 amRNSBlock listing Interim Review
14th May 20183:37 pmRNSHolding(s) in Company
30th Apr 20185:08 pmRNSTotal Voting Rights Update
27th Apr 20184:45 pmRNSAnnual Financial Report and Notice of AGM
26th Apr 20185:46 pmRNSHolding(s) in Company
26th Apr 20185:46 pmRNSHolding(s) in Company
24th Apr 20187:00 amRNSFinal Results
24th Apr 20187:00 amRNSIssue of Equity - AstraZeneca
12th Apr 20187:00 amRNSNotice of Results
29th Mar 20187:00 amRNSTotal Voting Rights
16th Mar 20184:40 pmRNSSecond Price Monitoring Extn
16th Mar 20184:35 pmRNSPrice Monitoring Extension
28th Feb 20182:01 pmRNSTotal Voting Rights
13th Feb 20187:00 amRNSDirectorate Change
8th Feb 20187:00 amRNSReceives Innovative Tech Contract from Vizient

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.